141 related articles for article (PubMed ID: 18566960)
1. Human tumour clonality assessment--flawed but necessary.
Leedham SJ; Wright NA
J Pathol; 2008 Aug; 215(4):351-4. PubMed ID: 18566960
[TBL] [Abstract][Full Text] [Related]
2. Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone.
Jovanovic L; Delahunt B; McIver B; Eberhardt NL; Grebe SK
J Pathol; 2008 Jun; 215(2):145-54. PubMed ID: 18393366
[TBL] [Abstract][Full Text] [Related]
3. Tumour heterogeneity and clonality--an old theme revisited.
Fey MF; Tobler A
Ann Oncol; 1996 Feb; 7(2):121-8. PubMed ID: 8777166
[No Abstract] [Full Text] [Related]
4. Clonality of pituitary tumours: more complicated than initially envisaged?
Clayton RN; Farrell WE
Brain Pathol; 2001 Jul; 11(3):313-27. PubMed ID: 11414474
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
Bignold LP
Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
[TBL] [Abstract][Full Text] [Related]
6. Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets.
Garcia SB; Park HS; Novelli M; Wright NA
J Pathol; 1999 Jan; 187(1):61-81. PubMed ID: 10341707
[TBL] [Abstract][Full Text] [Related]
7. A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues.
Luijts T; Elliott K; Siaw JT; Van de Velde J; Beyls E; Claeys A; Lammens T; Larsson E; Willaert W; Vral A; Van den Eynden J
Sci Rep; 2022 Jun; 12(1):10322. PubMed ID: 35725896
[TBL] [Abstract][Full Text] [Related]
8. Pituitary tumour clonality revisited.
Clayton RN; Farrell WE
Front Horm Res; 2004; 32():186-204. PubMed ID: 15281347
[TBL] [Abstract][Full Text] [Related]
9. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.
Yang M; Topaloglu U; Petty WJ; Pagni M; Foley KL; Grant SC; Robinson M; Bitting RL; Thomas A; Alistar AT; Desnoyers RJ; Goodman M; Albright C; Porosnicu M; Vatca M; Qasem SA; DeYoung B; Kytola V; Nykter M; Chen K; Levine EA; Staren ED; D'Agostino RB; Petro RM; Blackstock W; Powell BL; Abraham E; Pasche B; Zhang W
J Hematol Oncol; 2017 May; 10(1):100. PubMed ID: 28472989
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports.
Rojansky R; Fernandez-Pol S; Wang E; Rieger KE; Novoa RA; Zehnder JL; Kunder CA; Kim YH; Khodadoust MS; Brown RA
Diagn Pathol; 2020 Sep; 15(1):122. PubMed ID: 32988392
[TBL] [Abstract][Full Text] [Related]
11. Clonal architecture of secondary acute myeloid leukemia.
Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
[TBL] [Abstract][Full Text] [Related]
12. Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions.
Lyons JG; Lobo E; Martorana AM; Myerscough MR
Clin Exp Metastasis; 2008; 25(6):665-77. PubMed ID: 18071912
[TBL] [Abstract][Full Text] [Related]
13. Different clonal origin of B-cell populations of chronic lymphocytic leukemia and large-cell lymphoma in Richter's syndrome.
Matolcsy A; Casali P; Knowles DM
Ann N Y Acad Sci; 1995 Sep; 764():496-503. PubMed ID: 7486574
[TBL] [Abstract][Full Text] [Related]
14. PCR techniques for clonality assays.
Diaz-Cano SJ; Blanes A; Wolfe HJ
Diagn Mol Pathol; 2001 Mar; 10(1):24-33. PubMed ID: 11277392
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutation theory of carcinogenesis: why it should be dropped and replaced.
Sonnenschein C; Soto AM
Mol Carcinog; 2000 Dec; 29(4):205-11. PubMed ID: 11170258
[TBL] [Abstract][Full Text] [Related]
16. Polyclonal tumors in the mammalian intestine: are interactions among multiple initiated clones necessary for tumor initiation, growth, and progression?
Halberg RB; Dove WF
Cell Cycle; 2007 Jan; 6(1):44-51. PubMed ID: 17245117
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic analysis of tumor clonality.
Teixeira MR; Heim S
Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303
[TBL] [Abstract][Full Text] [Related]
18. Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas.
Simon E; Bick T; Sarji S; Shentzer T; Prinz E; Yehiam L; Sabo E; Ben-Izhak O; Hershkovitz D
Oncotarget; 2017 Jul; 8(28):45736-45749. PubMed ID: 28501852
[TBL] [Abstract][Full Text] [Related]
19. Inferring clonal structure in HTLV-1-infected individuals: towards bridging the gap between analysis and visualization.
Farmanbar A; Firouzi S; Makałowski W; Iwanaga M; Uchimaru K; Utsunomiya A; Watanabe T; Nakai K
Hum Genomics; 2017 Jul; 11(1):15. PubMed ID: 28697807
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia.
Martínez-Avilés L; Álvarez-Larrán A; Besses C; Navarro G; Torres E; Longarón R; Angona A; Pedro C; Florensa L; Serrano S; Bellosillo B
Ann Hematol; 2012 Oct; 91(10):1555-62. PubMed ID: 22706669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
